title: A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
abstract: MicroRNAs are small noncoding RNAs that have critical roles in regulating a number of cellular functions through transcriptional silencing. They have been implicated as oncogenes and tumor suppressor genes (oncomirs) in several human neoplasms. We used an integrated genomics and functional screening strategy to identify potential oncomirs in the pediatric neoplasm neuroblastoma. We first identified microRNAs that map within chromosomal regions that we and others have defined as frequently deleted (1p36, 3p22, and 11q23-24) or gained (17q23) in high-risk neuroblastoma. We then transiently transfected microRNA precursor mimics or inhibitors into a panel of six neuroblastoma cell lines that we characterized for these genomic aberrations. The majority of transfections showed no phenotypic effect, but the miR-34a (1p36) and miR-34c (11q23) mimics showed dramatic growth inhibition in cell lines with 1p36 hemizygous deletion. In contrast, there was no growth inhibition by these mimics in cell lines without 1p36 deletions. Quantitative reverse transcription-PCR showed a perfect correlation of absent miR-34a expression in cell lines with a 1p36 aberration and phenotypic effect after mimetic add-back. Expression of miR-34a was also decreased in primary tumors (n = 54) with 1p36 deletion (P = 0.009), but no mutations were discovered in resequencing of the miR-34a locus in 30 neuroblastoma cell lines. Flow cytometric time series analyses showed that the likely mechanism of miR-34a growth inhibition is through cell cycle arrest followed by apoptosis. BCL2 and MYCN were identified as miR-34a targets and likely mediators of the tumor suppressor phenotypic effect. These data support miR-34a as a tumor suppressor gene in human neuroblastoma.
authors.affiliation: Division of Oncology, Children's Hospital of Philadelphia, Abramson Pediatric Research Center 902A, 3615 Civic Center Boulevard, Philadelphia, PA 19104-4318, USA.
authors.forename: Kristina A
authors.initials: KA
authors.lastname: Cole
authors.forename: Edward F
authors.initials: EF
authors.lastname: Attiyeh
authors.forename: Yael P
authors.initials: YP
authors.lastname: Mosse
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Laquaglia
authors.forename: Sharon J
authors.initials: SJ
authors.lastname: Diskin
authors.forename: Garrett M
authors.initials: GM
authors.lastname: Brodeur
authors.forename: John M
authors.initials: JM
authors.lastname: Maris
mesh_terms: D017209:Apoptosis; D002453:Cell Cycle; D045744:Cell Line, Tumor; D017353:Gene Deletion; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D019254:Genes, bcl-2; D006801:Humans; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D009447:Neuroblastoma / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000378:metabolism; D013997:Time Factors
chemical_list: C522425:MIRN34 microRNA, human; D035683:MicroRNAs; D034741:RNA, Small Interfering